"Purpose: Primary surgery followed by platinum/taxane-based chemotherapy is the standard therapy in advanced ovarian cancer. The prognostic role of complete debulking has been well described; however, the impact of systematic pelvic and para-aortic lymphadenectomy and its interaction with biologic factors are still not fully defined.
Conclusion: Lymphadenectomy in advanced ovarian cancer
might offer benefit mainly to patients with complete
intraperitoneal debulking. However, this hypothesis should be
confirmed in the context of a prospectively randomized
trial."
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.